Super-potent synthetic opioids called nitazenes are spreading across the U.S.

Nitazenes, a class of potent synthetic opioids, are increasingly circulating in the United States, posing a significant public health threat. These substances, which can be up to 10 times more potent than fentanyl, are being detected in drug seizures and are linked to overdose deaths across various states. The Drug Enforcement Administration (DEA) has issued multiple alerts regarding the proliferation of nitazenes, noting their presence in counterfeit pills and as adulterants in other illicit drugs. For instance, in January 2024, the DEA reported the identification of nitazenes in drug samples from at least 10 states. The emergence of nitazenes complicates efforts to combat the ongoing opioid crisis, as they may not be detected by standard drug testing panels and require different treatment protocols. Public health officials are urging increased awareness and enhanced surveillance to monitor the spread and impact of these dangerous compounds. The case of Ashley Delgado, who transitioned from prescription opioids to fentanyl and ultimately succumbed to an overdose, highlights the perilous trajectory of opioid addiction, with nitazenes representing a new and formidable challenge in this crisis.